Search alternatives:
comparative efficacy » comparative effects (Expand search), collective efficacy (Expand search)
decrease comparative » disease comparative (Expand search), case comparative (Expand search), decrease cooperation (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease toc » decrease of (Expand search), decrease the (Expand search), decrease on (Expand search)
toc decrease » to decrease (Expand search), the decrease (Expand search), not decrease (Expand search)
or decrease » not decrease (Expand search), to decrease (Expand search), _ decrease (Expand search)
decrease or » decrease of (Expand search), decrease on (Expand search), decrease pro (Expand search)
comparative efficacy » comparative effects (Expand search), collective efficacy (Expand search)
decrease comparative » disease comparative (Expand search), case comparative (Expand search), decrease cooperation (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease toc » decrease of (Expand search), decrease the (Expand search), decrease on (Expand search)
toc decrease » to decrease (Expand search), the decrease (Expand search), not decrease (Expand search)
or decrease » not decrease (Expand search), to decrease (Expand search), _ decrease (Expand search)
decrease or » decrease of (Expand search), decrease on (Expand search), decrease pro (Expand search)
1
“... decrease in headache frequency (p=0.001), moderate intensity (p=0.048), in headache duration (p=0.001), the...”
Access document
Access document
Article
2
“... decrease in headache frequency (p=0.001), moderate intensity (p=0.048), in headache duration (p=0.001), the...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
3
4
5
6
7
“... systems aims to enhance bioavailability and to decrease toxicity of these drugs and thus improve the...”
Access document
Access document
Article
8
9
10
COMPARATIVE ANALYSIS OF THE USE OF STATINS AND NICOTINIC ACID IN THE TREATMENT OF METABOLIC SYNDROME
“... the use of statins and nicotinic acid in the treatment of MS. To this end, a comparative analysis...”Access document
Article
11
“...Objective: To assess the efficacy and safety of topical 5% cysteamine versus 4% hydroquinone in the...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
12
13
14
15
16
17
“... TPS and decrease BFS. Methods: This is a prospective, randomized, comparative, case series study...”
Access document
Access document
Article
18
“...Aim: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
19
“...Aim: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes...”
Access document
Access document
Article
20